T. Rowe Price Associates’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428K | Buy |
39,402
+3,401
| +9% | +$36.9K | ﹤0.01% | 2373 |
|
|
2025
Q1 | $667K | Buy |
36,001
+1,181
| +3% | +$21.9K | ﹤0.01% | 2139 |
|
|
2024
Q4 | $574K | Buy |
34,820
+3,220
| +10% | +$53.1K | ﹤0.01% | 2223 |
|
|
2024
Q3 | $444K | Buy |
31,600
+427
| +1% | +$6K | ﹤0.01% | 2304 |
|
|
2024
Q2 | $226K | Buy |
31,173
+1,523
| +5% | +$11K | ﹤0.01% | 2543 |
|
|
2024
Q1 | $240K | Buy |
29,650
+2,204
| +8% | +$17.8K | ﹤0.01% | 2533 |
|
|
2023
Q4 | $188K | Sell |
27,446
-3,822
| -12% | -$26.2K | ﹤0.01% | 2560 |
|
|
2023
Q3 | $157K | Buy |
31,268
+9,504
| +44% | +$47.7K | ﹤0.01% | 2562 |
|
|
2023
Q2 | $199K | Buy |
21,764
+180
| +0.8% | +$1.65K | ﹤0.01% | 2530 |
|
|
2023
Q1 | $204K | Sell |
21,584
-1
| -0% | -$9 | ﹤0.01% | 2516 |
|
|
2022
Q4 | $215K | Buy |
21,585
+830
| +4% | +$8.27K | ﹤0.01% | 2497 |
|
|
2022
Q3 | $248K | Buy |
20,755
+2,526
| +14% | +$30.2K | ﹤0.01% | 2462 |
|
|
2022
Q2 | $149K | Sell |
18,229
-334
| -2% | -$2.73K | ﹤0.01% | 2662 |
|
|
2022
Q1 | $147K | Buy |
18,563
+7,683
| +71% | +$60.8K | ﹤0.01% | 2766 |
|
|
2021
Q4 | $102K | Sell |
10,880
-445
| -4% | -$4.17K | ﹤0.01% | 2867 |
|
|
2021
Q3 | $179K | Sell |
11,325
-100
| -0.9% | -$1.58K | ﹤0.01% | 2743 |
|
|
2021
Q2 | $247K | Buy |
11,425
+825
| +8% | +$17.8K | ﹤0.01% | 2642 |
|
|
2021
Q1 | $215K | Buy |
+10,600
| New | +$215K | ﹤0.01% | 2664 |
|
|
2016
Q1 | – | Sell |
-75,914
| Closed | -$380K | – | 2505 |
|
|
2015
Q4 | $380K | Buy |
+75,914
| New | +$380K | ﹤0.01% | 2067 |
|